To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04789655
Title Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | CAN

Facility Status City State Zip Country Details
Local Institution - 109 Birmingham Alabama 35233 United States Details
Local Institution - 105 Jacksonville Florida 32224 United States Details
Local Institution - 108 Atlanta Georgia 30322 United States Details
Local Institution - 110 Rochester Minnesota 55905 United States Details
Local Institution - 101 Hackensack New Jersey 07601 United States Details
Local Institution - 102 New York New York 10029 United States Details
Local Institution - 107 Houston Texas 77030-4009 United States Details
Local Institution - 111 Seattle Washington 98104 United States Details
Local Institution - 202 Calgary Alberta T2N 5G2 Canada Details
Local Institution - 201 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 303 Marseille cedex 13273 France Details
Local Institution - 304 Paris 75010 France Details
Local Institution - 301 Pessac Cedex 33604 France Details
Local Institution - 302 Villejuif CEDEX 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field